Últimas noticias sobre Altria Group (NYSE:MO) Bolsa

Altria Group

Altria comprises Philip Morris USA, us Smokeless Tobacco, John Middleton, Horizon Innovations, and Helix Innovations. Through its tobacco subsidiaries, Altria maintains the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the us with 42% annual share in 2023. Beyond its core business, it holds an 8% interest in the world's largest brewer, Anheuser-Busch InBev, a 42% stake in cannabis manufacturer Cronos, acquired Njoy Holdings in 2023, and operates a joint venture with Japan Tobacco in the heated tobacco category. It also recently disposed of its investment in Juul Labs.

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

Acciones de Altria y Kellanova muestran altos niveles de RSI, señalando posible sobrecompra. ¿Qué significa para los inversores?

2 acciones de riesgo que podrían colapsar en septiembre

Altria Group Inc

MONGOLIA ENERGY CORP by Mongolia Energy Corp., Ltd.

Mongolia Energy Corp Ltd

MONGOLIA ENGY CP UNSP/ADR by Mongolia Energy Corp., Ltd.

VanEck Morningstar Wide Moat ETF

Mobilicom Limited - American Depositary Shares

Mobilicom Ltd

MobileCoin - United States Dollar

Mobius

MOBI724 GLOB SOLUTNS INC by MOBI724 GLOBAL SOLUTIONS INC

Mobi724 Global Solutions Inc

Helium Mobile - United States Dollar

M O B A NETWORK AB by M.O.B.A. Network AB

MOBA Network AB

Mobile Lads Corp

MOBIQUITY TECH INC by Mobiquity Technologies, Inc.

Mobiquity Technologies Inc

Mobiquity Technologies Inc Warrants (30/11/2026)

MOBIV ACQUISITION CORP CL A

MOBIV ACQUISITION CORP UNIT 1 CL A & 1 RED WT EXP

Mobiv Acquisition Corp Warrants (31/07/2027)

Mobiv Acquisition Corp

Mobix Labs Inc

Moss Coin

MODERN CINEMA GROUP INC by Modern Cinema Group, Inc.

Modern Cinema Group Inc

Modine Manufacturing Company Common Stock

Modine Manufacturing Co

Modefi

MODERN TECH CORP by Modern Technology Corp.

Modern Technology Corp

Modular Medical Inc

Mode Network - United States Dollar

Topgolf Callaway Brands Corp. Common Stock

Topgolf Callaway Brands Corp

R8 Capital Investments PLC

VictoryShares WestEnd U.S. Sector ETF

MODEL N INC COM

ModivCare Inc

MELCOR DEV LTD by Melcor Development Ltd.

Melcor Developments Ltd

Molecular Future

MidWestOne Financial Group, Inc. - Common Stock

MidWestOne Financial Group Inc

Moog Inc

Mog Coin - United States Dollar

MONGOLIAN MINING CORP by Mongolian Mining Corp.

Mongolian Mining Corp

MOGOTES METALS INC by MOGOTES METALS INC

Mogo Inc

MOGU Inc. American Depositary Shares (each representing 25 Class A Ordinary Shares)

MOGU Inc

Molina Healthcare Inc

MOTOR OIL HELLAS CORINTH by Motor Oil (Hellas) Corinth Refineries S.A.

Motor Oil (Hellas) Corinth Refineries SA

MOTOR OIL HELLAS UNSP/ADR by Motor Oil (Hellas) Corinth Refineries S.A.

Collaborative Investment Series Trust Mohr Growth ETF

EQUATOR BEVERAGE COMPANY by Equator Beverage Company

Equator Beverage Co

MOL Hungarian Oil and Gas PLC

Molecular Partners AG - American Depositary Shares

Molecular Partners AG

Hello Group Inc. - American Depositary Shares

Hello Group Inc

MoneyOnMobile Inc

Monavale - United States Dollar

MONDEE HLDGS INC A by Mondee Holdings, Inc.

Mondee Holdings Inc

Mondi PLC ADR

Mondi PLC

MONTEGO RESOURCES INC by Montego Resources Inc.

Montego Resources Inc

MOON EQUITY HLDGS CORP by MOON EQUITY HLDGS CORP.

Moon Equity Hldgs Corp

Monsta Infinite

MONK

MONOTARO CO LTD ORD by Monotaro Co., Ltd.

MonotaRO Co Ltd

MONOTARO CO LTD UNSP/ADR by Monotaro Co., Ltd.

Moncler SpA

Montea NV

MONTFORT CAPITAL CORP by Montfort Capital Corp.

Montfort Capital Corp

VanEck Agribusiness ETF

Relative Sentiment Tactical Allocation ETF

BLUE HORIZON GLOBAL CAP by BLUE HORIZON GLOBAL CAP CORP.

Blue Horizon Global Capital Corp

Direxion Shares Exchange Traded Fund Trust Moonshot Innovators ETF

Dog on Moon - United States Dollar

BETTERMOOD FOOD CORP by BETTERMOOD FOOD CORP.

Bettermoo(d) Food Corp

Dotmoovs

MONADELPHOUS GRP UNSP/ADR by Monadelphous Group Ltd

Monadelphous Group Ltd

MOLINOS RIO DE LA PLATA B by Molinos Rio de La Plata

Molinos Rio De La Plata SA

MOP ENVIRONMENTAL SLTNS by MOP Environmental Solutions, Inc.

MOP Environmental Solutions Inc

MORPHOSYS AG SPONSORED ADS

MORPHIC HLDG INC COM

MORITO CO LTD ORD by Morito Co., Ltd.

Morningstar Inc

HOSTMORE PLC by Hostmore PLC

VanEck Mortgage REIT Income ETF

The Mosaic Co

MobileSmith Inc

VanEck Morningstar ESG Moat ETF

VanEck Morningstar Global Wide Moat ETF

VanEck Morningstar International Moat ETF

PowerTap Hydrogen Capital Corp

POWERTAP HYDROGN CAP CORP by Powertap Hydrogen Capital Corp.

SmartETFs Smart Transportation & Technology ETF

MOTUS GI HOLDINGS INC by Motus GI Holdings, Inc.

Motus GI Holdings Inc

Movado Group Inc

MOVADO GROUP INC A by Movado Group, Inc.

Movano Inc

Moonriver - United States Dollar

Mynaric AG

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.
<h3 class="wp-block-heading">Walgreens Boots Alliance, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>)</h3>
<ul>
<li>Dividend Yield: 10.16%</li>
<li>RBC Capital analyst Ben Hendrix maintained a Sector Perform rating and cut the price target from $13 to $9 on Dec. 4. This analyst has an accuracy rate of 66%.</li>
<li>Jefferies analyst Brian Tanquilut maintained a Hold rating and cut the price target from $19 to $9 on Oct. 23. This analyst has an accuracy rate of 61%.</li>
<li>Recent News: Walgreens Boots Alliance shares rose Tuesday afternoon following a report suggesting the company is in talks to be acquired by a private-equity firm.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121224&amp;t=be2bearmibe3na1">latest WBA news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121224&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="906" height="822" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084557/image-99.png" alt="" class="wp-image-689505" style="width:561px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084557/image-99.png 906w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084557/image-99-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084557/image-99-768x697.png 768w" sizes="(max-width: 906px) 100vw, 906px" /></a></figure>
<h3 class="wp-block-heading">Altria Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>)</h3>
<ul>
<li>Dividend Yield: 7.46%</li>
<li>B of A Securities analyst Lisa Lewandowski upgraded the stock from Neutral to Buy and raised the price target from $55 to $65 on Dec. 6. This analyst has an accuracy rate of 62%.</li>
<li>Barclays analyst Gaurav Jain maintained an Underweight rating and raised the price target from $45 to $46 on Nov. 6. This analyst has an accuracy rate of 61%.</li>
<li>Recent News: On Oct. 31, Altria Group reported better-than-expected third-quarter adjusted EPS results.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121224&amp;t=be2bearmibe3na1">latest MO news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121224&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="800" height="777" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084632/image-100.png" alt="" class="wp-image-689506" style="width:593px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084632/image-100.png 800w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084632/image-100-300x291.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084632/image-100-768x746.png 768w" sizes="(max-width: 800px) 100vw, 800px" /></a></figure>
<h3 class="wp-block-heading">The Kraft Heinz Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>)</h3>
<ul>
<li>Dividend Yield: 5.11%</li>
<li>Piper Sandler analyst Michael Lavery downgraded the stock from Overweight to Neutral and cut the price target from $40 to $35 on Nov. 19. This analyst has an accuracy rate of 64%.</li>
<li>Mizuho analyst John Baumgartner maintained an Outperform rating and cut the price target from $43 to $41 on Oct. 31. This analyst has an accuracy rate of 73%.</li>
<li>Recent News: On Oct. 30, Kraft Heinz posted third-quarter earnings of 75 cents per share, beating estimates, but reported a revenue decline and anticipates a prolonged recovery in U.S. retail..</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121224&amp;t=be2bearmibe3na1">trend in KHC stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121224&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="928" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084710/image-101.png" alt="" class="wp-image-689507" style="width:570px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084710/image-101.png 928w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084710/image-101-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/12084710/image-101-768x701.png 768w" sizes="(max-width: 928px) 100vw, 928px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42437595/jim-cramer-says-keep-owning-this-energy-stock-abbott-laboratories-legal-stuff-is-behind-them">Jim Cramer Says &#8216;Keep Owning&#8217; This Energy Stock, Abbott Laboratories &#8216;Legal Stuff&#8217; Is Behind Them</a></li>
</ul>

Price Target

Analyst Ratings

Wall Street's Most Accurate Analysts Weigh In On 3 Risk Off Care Stocks With Over 5% Dividend Yields

<a href="https://www.nytimes.com/2024/12/11/health/fda-low-nicotine-cigarettes-biden.html" title="https://www.nytimes.com/2024/12/11/health/fda-low-nicotine-cigarettes-biden.html">https://www.nytimes.com/2024/12/11/health/fda-low-nicotine-cigarettes-biden.html</a>

"F.D.A. Tries Last-Ditch Move to Slash Nicotine Levels in Cigarettes; The agency is asking the White House to move ahead with plans to drastically reduce the addictive substance in traditional tobacco cigarettes." - NY Times

Biotech

General

XXII

Lilly CEO Says To Test Obesity Drugs For Smoking, Alcohol Abuse

B of A Securities analyst Lisa Lewandowski upgrades Altria Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) from Neutral to Buy and raises the price target from $55 to $65.

Upgrades

B of A Securities Upgrades Altria Group to Buy, Raises Price Target to $65

Altria Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) short percent of float has risen 10.83% since its last report. The company recently reported that it has 29.46 million shares sold short, which is 1.74% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.97 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Altria Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1733408111_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Altria Group has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Altria Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Altria Group's peer group average for short interest as a percentage of float is 1.61%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Looking Into Altria Group's Recent Short Interest

The U.S. Supreme Court heard a challenge against the Food and Drug Administration (FDA) Monday about past bans on flavored liquids for<a href="https://www.benzinga.com/topic/vaping"> e-cigarettes and vapes.</a>
What Happened: Triton Distribution brought a case to the<a href="https://www.benzinga.com/topic/supreme-court"> U.S. Supreme Court</a>, challenging the law that allows the FDA to control the regulation of e-liquids and e-cigarettes.
The FDA previously denied Triton&#8217;s applications to sell flavored e-cigarettes. The concern is that they could appeal to children and teenagers, as reported by <a href="https://www.politico.com/news/2024/12/02/supreme-court-vaping-firm-fda-00192164">Politico</a>.  
Cigarette flavors, except menthol, have been banned by the FDA since 2009.
A final ruling will not be made by the Supreme Court for months. Justices, though, don&#8217;t appear to sympathize with Triton's argument.
"Everybody basically knows that flavors are particularly dangerous in terms of kids starting the use of smoking products," Justice Elena Kagan said.
Triton has the potential to reapply with the FDA. A company attorney said the incoming Donald Trump administration could make things easier, given his past comments on wanting to <a href="https://www.usatoday.com/story/news/politics/2024/12/02/supreme-court-trump-flavored-vapes/76693085007/">save</a> vaping.
Some judges believed the FDA was not consistent on its approval process.
"Their argument is that the guidance were actually a moving target, that either they weren't clear, or you changed the guidance as time went on," Justice Clarence Thomas said.
Read Also: <a href="https://www.benzinga.com/news/24/09/40969670/trump-vows-to-save-vaping-again-despite-past-partial-ban-heres-how-he-plans-to-do-it">Trump Vows To &#8216;Save Vaping Again&#8217; Despite Past Partial Ban. Here&#8217;s How He Plans To Do It</a>
Why It's Important: Under the existing 2009 law, the FDA only approves new tobacco products if they believe they will protect public health. This makes it harder to get new products approved, as the system favors those fighting to get current users of products to stop smoking or prevent new users from starting.
Past appeals courts have approved the FDA's decisions, as reported by <a href="https://www.npr.org/2024/12/02/nx-s1-5205471/fda-vaping-supreme-court">NPR</a>. The conservative Fifth Circuit Court of Appeals rejected the FDA's decision capabilities. It also threatened to allow all vaping products to hit the market, prompting the challenge with the Supreme Court.
With a final ruling likely in June, cigarette and vaping companies could be on the radar of investors.
Cigarette manufacturer Altria Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) owns the NJOY menthol e-cigarette product that has flavored vapes approved by the FDA. Altria was previously an investor in Juul, a leader in the e-cigarette sector. It eventually exchanged its stake for some intellectual property.
Maintaining the FDA's current rules would keep Altria as one of the only companies that can sell approved flavored e-cigarettes. A different decision could see Altria quickly face increased competition.
British American Tobacco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTI#NYSE">BTI</a>) has watched previous attempts to have some vaping products approved denied by the FDA.
Turning Point Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPI#NYSE">TPI</a>), a past challenger to the FDA's approval process, could benefit if the Supreme Court puts new rules in place.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/10/41516090/social-media-reacts-as-juul-users-get-compensation-through-venmo-after-300m-class-action-settlements">Social Media Reacts As Juul Users Get Compensation Through Venmo After $300M Class-Action Settlements: &#8216;Vaping Actually Paid Off&#8217;</a></li>
</ul>
Image: Shutterstock

Legal

Supreme Court Hears Case Against FDA Ban On Flavored Vapes: Here Are The Stocks To Watch

WIIM

Shares of housing and building-related stocks are trading lower. Building permits and new home sales fell in October.

U.S. Supreme Court Declines To Decide Whether Certain Federally Mandated Health Warnings On Cigarette Packs Violate Tobacco Companies' Free Speech Protections

On CNBC's &#8220;<a href="https://www.benzinga.com/topic/mad-money-lightning-round">Mad Money Lightning Round</a>,&#8221; Jim Cramer said Altria Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) is &#8220;undervalued,&#8221; but he is not going to <a href="https://www.benzinga.com/quote/MO/guidance">recommend tobacco stocks</a>.
On Oct. 31, the company reported third-quarter adjusted earnings per share of $1.38. It beat the street view of $1.35. Quarterly sales of $5.334 billion (+1.3%) beat the analyst consensus estimate of $5.326 billion.
Cramer recommended selling Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>).
Super Micro Computer filed a FormNT 10-Q with the Securities and Exchange Commission, indicating that it's unable to file its 2025 fiscal-year first-quarter earnings on time.
When asked about The Boeing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>), he said, &#8220;I prefer not to be in a stock that is going to lose a lot of money for a long time.&#8221;
According to Reuters, the company reportedly begins issuing layoff notices to employees affected by a major restructuring plan. The plan, which aims to reduce Boeing's global workforce by 17,000 jobs—approximately 10% of its total—comes as the heavily indebted aerospace <a href="https://www.benzinga.com/trading-ideas/movers/24/11/41950702/boeing-reportedly-plans-furloughs-whats-going-on">giant seeks to cut costs</a>.
Becton, Dickinson and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDX#NYSE">BDX</a>) has &#8220;broken down severely,&#8221; Cramer said. &#8220;If Robert F. Kennedy Jr. is going to be the head of HHS, then it's going to hurt a lot of vaccines, it could hurt a lot of their business.&#8221;
On Nov. 7, the company posted better-than-expected results for its fourth quarter.
&#8220;They have a lot of phase one stuff, and phase one is might early. Too early for me to bet on,&#8221; Cramer said when asked about IDEAYA Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDYA#NASDAQ">IDYA</a>).
On Nov. 4, IDEAYA Biosciences reported a quarterly loss of 60 cents per share, compared to consensus estimates of a loss of 64 cents per share.
&#8220;I just don't know what is wrong,&#8221; Cramer said about AstraZeneca PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>). &#8220;My god is this thing going lower.&#8221;
On Nov. 12, AstraZeneca reported third-quarter sales of $13.57 billion, up 18% year over year (+21% at constant currency), beating the consensus of $13.09 billion.
Price Action:
<ul>
<li>Altria shares rose 0.3% to settle at $55.39 on Thursday.</li>
<li>Super Micro Computer shares dipped 11.4% to close at $18.01.</li>
<li>Boeing shares fell 1.3% to settle at $138.14 during the session.</li>
<li>Becton Dickinson shares fell 1.8% to close at $227.17 on Thursday.</li>
<li>IDEAYA Biosciences shares fell 3.4% to settle at $29.47 during the session.</li>
<li>AstraZeneca shares fell 0.4% to close at $65.04 on Thursday.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41971544/jim-cramer-recommends-microsoft-praises-american-water-works-for-being-consistent">Jim Cramer Recommends Microsoft, Praises American Water Works For Being &#8216;Consistent&#8217;</a></li>
</ul>
Image: Shutterstock

Long Ideas

Media

IDYA

SMCI

Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It

Barclays analyst Gaurav Jain maintains Altria Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) with a Underweight and raises the price target from $45 to $46.

Barclays Maintains Underweight on Altria Group, Raises Price Target to $46

Deutsche Bank analyst Gerry Gallagher maintains Altria Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) with a Buy and raises the price target from $52 to $60.

Deutsche Bank Maintains Buy on Altria Group, Raises Price Target to $60

Stifel analyst Matthew Smith maintains Altria Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) with a Buy and raises the price target from $54 to $60.

Stifel Maintains Buy on Altria Group, Raises Price Target to $60

Risk aversion swept across markets on Thursday as investor disappointment over third-quarter tech earnings triggered the steepest drop in major U.S. indices <a href="https://www.benzinga.com/markets">in nearly two months.</a>
Microsoft Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NYSE">MSFT</a>) plummeted over 5% by midday trading in New York, on track for its worst session in two years. Although the company surpassed earnings estimates, it forecasted slower growth in its Azure cloud business, dampening future revenue expectations.
Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) also declined by over 4% despite a strong quarterly performance, as the social media giant projected &#8220;significant&#8221; capital expenditure growth next year, particularly for AI infrastructure.
The elite &#8220;Magnificent Seven&#8221; tech group shed nearly $500 billion in market capitalization within a single day after reaching a record high of $16.8 trillion. Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) are set to report earnings after the market close.
In economic news, inflation sent mixed signals for September. The Personal Consumption Expenditures (PCE) price index slowed as expected to 2.1% annually, while the Fed's preferred inflation measure, the core PCE price index, remained at 2.7% year over year, slightly <a href="https://www.benzinga.com/economics/macro-economic-events/24/10/41658542/fed-interest-rate-cuts-expected-but-economists-warn-of-bumpy-course-in-this-last-">above the expected 2.6%.</a>
The S&amp;P 500 dropped 1.4%, and the tech-heavy Nasdaq 100 slid 2.2%, both tracking their worst session since Sept. 6. The CBOE Volatility Index (VIX) surged 12%.
Risk aversion also weighed on commodities, with gold prices dropping 1.7%, marking their worst day since July, and silver plunging 3% after a 2% decline on Wednesday. 
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) slid 2.4%, and crypto-related stocks suffered significant losses. Coinbase Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) tumbled over 10% on disappointing earnings, eyeing its worst day since May.
<h3 class="wp-block-heading">Thursday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>41,832.30</td>
<td>-0.7%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,213.10</td>
<td>-0.9%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,729.43</td>
<td>-1.4%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,943.07</td>
<td>-2.2%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:20 p.m. ET</figcaption></figure>
According to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent103124&amp;t=be2bearmibe3na1">Benzinga Pro</a> data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 1.5% to $571.51.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;fell 0.8% to $418.60.</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) tumbled 2.2% to $485.78. </li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) fell 0.7% to $219.65.</li>
<li>The Utilities Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) outperformed, rising 1.4%. The Technology Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) lagged, down 2.4%.</li>
</ul>
<h3 class="wp-block-heading">Thursday&#8217;s Stock Movers</h3>
Stocks reacting to corporate earnings were: 
<ul>
<li>Booking Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>), up over 5%, </li>
<li>Amgen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>), up 1.7%,</li>
<li>Starbucks Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NYSE">SBUX</a>), down 0.6%, </li>
<li>eBay Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>), down over 8%, </li>
<li>MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), up 1.9%,</li>
<li>Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>), up 24%,</li>
<li>Mastercard Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>), down 1.8%, </li>
<li>Merck &amp; Company Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>), down 2.8%,</li>
<li>Linde plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIN#NASDAQ">LIN</a>), down 2.9%, </li>
<li>Comcast Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMCSA#NASDAQ">CMCSA</a>), up 2.9%, </li>
<li>Uber Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>), down over 11%, </li>
<li>Eaton Corp. plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>), down 5%, </li>
<li>ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>), up 6%, </li>
<li>Bristo-Myers Squibb Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>), up 3.3%, </li>
<li>Southern Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SO#NYSE">SO</a>), up 2.2%, </li>
<li>Altria Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>), up 7.6%, </li>
<li>Regeneron Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>), down 9%, </li>
<li>The Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>), up 3%, </li>
<li>Norwegian Cruise Line Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>), up over 9%. </li>
<li>Cheniere Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNG#NYSE">LNG</a>), up over 5%. </li>
</ul>
Large-cap companies slated to report their earnings after the close include Apple Inc, Amazon.com Inc, Intel Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>), Atlassian Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) and Coterra Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRA#NYSE">CTRA</a>).
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41658754/microsoft-in-major-growth-mode-not-slowing-down-4-analysts-see-strong-azure-demand-">Microsoft &#8216;In Major Growth Mode,&#8217; Not Slowing Down: 4 Analysts See Strong Azure Demand, AI Monetization Efforts</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Equities

Large Cap

Macro Economic Events

Mid Cap

Broad U.S. Equity ETFs

Commodities

Econ #s

Economics

Federal Reserve

Tech

ETFs

$BTC

AAPL

AMGN

AMZN

BKNG

CMCSA

COIN

CTRA

CVNA

SPDR Dow Jones Industrial Average ETF Trust

EBAY

INTC

MSFT

MSTR

NCLH

REGN

SBUX

TEAM

UBER

Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?

Altria Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) shares are <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">trading higher on Thursday.</a>
The company reported third-quarter adjusted earnings per share of $1.38, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/b41648697/altria-reports-2024-third-quarter-and-nine-months-results-reaffirms-2024-full-year-earnings-guidan" rel="noreferrer noopener">beating the street view of $1.35.</a> Quarterly sales of $5.334 billion (+1.3%) beat the analyst consensus estimate of $5.326 billion.
Smokeable products segment reported domestic cigarette shipment volume decreased&nbsp;8.6%, primarily due to the industry&#8217;s decline rate and retail share losses, partially offset by trade inventory movements and calendar differences. Marlboro shipment volume fell 7.5% in the quarter.
Also, Marlboro&nbsp;retail share of the total cigarette category was&nbsp;41.7%, down 0.6 share points versus the prior year and 0.3 share points sequentially.
NJOY reported a 15.6% increase in consumables shipment volume to 10.4 million units and a 100% rise in device shipments to 1.1 million units. Additionally, their retail share of consumables in the U.S. multi-outlet and convenience channel grew by 2.8 percentage points to 6.2%.
&#8220;The smokeable products segment delivered solid operating companies income growth behind the resilience of&nbsp;Marlboro, and in the oral tobacco products segment, our MST brands continued to drive profitability while&nbsp;on!&nbsp;maintained momentum in the marketplace,&#8221; said Billy Gifford, Altria&#8217;s Chief Executive Officer.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41657705/peloton-gears-up-for-next-chapter-sales-beat-apple-alum-as-ceo-and-strong-margin-gains" rel="noreferrer noopener">Peloton Gears Up For Next Chapter: Sales Beat, Apple Alum As CEO, And Strong Margin Gains</a>
Altria plans to&nbsp;establish an Accelerated Business Solutions organization within Altria Client Services. This organization will be responsible for driving efficiency.
&#8220;We expect the initial phases of the Initiative will deliver at least $600 million in cumulative cost savings over the next five years,&#8221; the company said.
The cumulative cost savings exclude the company&#8217;s estimated total pre-tax charges for initial phases of approximately $100 million to $125 million.
In the third quarter, the company repurchased a total of 13.5 million shares at an average price of $50.37, amounting to $680 million, while for the first nine months, the repurchases totaled 67.6 million shares at an average price of $45.68, totaling $3.1 billion.
&#8220;We maintain our progressive dividend goal that targets mid-single digits dividend per share growth annually through 2028,&#8221; the company said.
Outlook: The company reaffirms its guidance for 2024, projecting adjusted diluted EPS to range from $5.07 to $5.15 (estimate: $5.10). This reflects a growth rate of 2.5% to 4% compared to the 2023 base of $4.95, with <a href="https://www.benzinga.com/calendars/guidance">anticipated growth weighted toward the second half of the year.</a>
Price Action: MO shares are trading higher by 8.36% to $54.72 at last check Thursday.
Image by svklimkin from Pixabay
Also Read:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41653721/est-e-lauder-q1-earnings-china-uncertainty-hits-beauty-giant-withdraws-fy25-outlook-stock-tanks" target="_blank" rel="noreferrer noopener">Estée Lauder Q1 Earnings: China Uncertainty Hits Beauty Giant, Withdraws FY25 Outlook, Stock Tanks</a></li>
</ul>

Comments

Altria Group

Noticias

Últimas noticias sobre Altria Group (NYSE:MO) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL